Sensus Healthcare, Inc. (NASDAQ:SRTS) reported Q2 EPS of $0.21, $0.08 better than the analyst estimate of $0.13. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.56 million.
Sensus Healthcare, Inc. (NASDAQ:SRTS) reported Q2 EPS of $0.21, $0.08 better than the analyst estimate of $0.13. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.56 million.